BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9699672)

  • 1. The murine Fhit locus: isolation, characterization, and expression in normal and tumor cells.
    Pekarsky Y; Druck T; Cotticelli MG; Ohta M; Shou J; Mendrola J; Montgomery JC; Buchberg AM; Siracusa LD; Manenti G; Fong LY; Dragani TA; Croce CM; Huebner K
    Cancer Res; 1998 Aug; 58(15):3401-8. PubMed ID: 9699672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region.
    Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG
    Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of PKCI and comparative studies with FHIT, related members of the HIT protein family.
    Klein MG; Yao Y; Slosberg ED; Lima CD; Doki Y; Weinstein IB
    Exp Cell Res; 1998 Oct; 244(1):26-32. PubMed ID: 9770345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant splicing of FHIT transcripts in human gastric cancer cell lines.
    Lee SH; Kim HY; Kim TJ; Park HK; Kim WH; Woo KM; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):39-49. PubMed ID: 15080495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and expression of the human FHIT gene in normal and tumor cells.
    Druck T; Hadaczek P; Fu TB; Ohta M; Siprashvili Z; Baffa R; Negrini M; Kastury K; Veronese ML; Rosen D; Rothstein J; McCue P; Cotticelli MG; Inoue H; Croce CM; Huebner K
    Cancer Res; 1997 Feb; 57(3):504-12. PubMed ID: 9012482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the mechanisms of FHIT inactivation in cervical cancer for biomarker development.
    Lea JS; Ashfaq R; Muneer S; Burbee DG; Miller DS; Minna JD; Muller CY
    J Soc Gynecol Investig; 2004 Jul; 11(5):329-37. PubMed ID: 15219888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragile histidine triad transcription abnormalities and human papillomavirus E6-E7 mRNA expression in the development of cervical carcinoma.
    Segawa T; Sasagawa T; Yamazaki H; Sakaike J; Ishikawa H; Inoue M
    Cancer; 1999 May; 85(9):2001-10. PubMed ID: 10223242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
    Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
    BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FHIT gene is expressed in pancreatic ductular cells and is altered in pancreatic cancers.
    Sorio C; Baron A; Orlandini S; Zamboni G; Pederzoli P; Huebner K; Scarpa A
    Cancer Res; 1999 Mar; 59(6):1308-14. PubMed ID: 10096564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Fhit protein in primary lung tumors and cell lines with FHIT gene abnormalities.
    Sozzi G; Tornielli S; Tagliabue E; Sard L; Pezzella F; Pastorino U; Minoletti F; Pilotti S; Ratcliffe C; Veronese ML; Goldstraw P; Huebner K; Croce CM; Pierotti MA
    Cancer Res; 1997 Dec; 57(23):5207-12. PubMed ID: 9393735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal transcripts of FHIT gene in thyroid cancer.
    Chang TJ; Tsai TC; Wu YL; Yang HM; Chi CW; Yang AH; Lee CH
    Oncol Rep; 1998; 5(1):245-7. PubMed ID: 9458330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant FHIT mRNA transcripts are present in malignant and normal haematopoiesis, but absence of FHIT protein is restricted to leukaemia.
    Peters UR; Hasse U; Oppliger E; Tschan M; Ong ST; Rassool FV; Borisch B; Tobler A; Fey MF
    Oncogene; 1999 Jan; 18(1):79-85. PubMed ID: 9926922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the FHIT gene in human hepatocellular carcinoma.
    Yuan BZ; Keck-Waggoner C; Zimonjic DB; Thorgeirsson SS; Popescu NC
    Cancer Res; 2000 Feb; 60(4):1049-53. PubMed ID: 10706123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the fragile histidine triad gene in normal rat tissues and human kidney cancer cell lines.
    Lee SH; Kim TJ; Kim HY; Kim JG; Park MK; Woo KM; Kim SH; Hwang KY; Nam HS; Min YK; Cho MH
    Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):145-57. PubMed ID: 15080505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines.
    Simon B; Bartsch D; Barth P; Prasnikar N; Münch K; Blum A; Arnold R; Göke B
    Cancer Res; 1998 Apr; 58(8):1583-7. PubMed ID: 9563464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of the FHIT gene in human prostate cancer.
    Latil A; Bièche I; Fournier G; Cussenot O; Pesche S; Lidereau R
    Oncogene; 1998 Apr; 16(14):1863-8. PubMed ID: 9583683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of FHIT transcripts in normal and malignant breast tissue.
    Bièche I; Latil A; Becette V; Lidereau R
    Genes Chromosomes Cancer; 1998 Dec; 23(4):292-9. PubMed ID: 9824201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.
    Panagopoulos I; Pandis N; Thelin S; Petersson C; Mertens F; Borg A; Kristoffersson U; Mitelman F; Aman P
    Cancer Res; 1996 Nov; 56(21):4871-5. PubMed ID: 8895736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent aberration of FHIT gene expression in acute leukemias.
    Iwai T; Yokota S; Nakao M; Nakazawa N; Taniwaki M; Kimura T; Sonoda Y; Kaneko H; Okuda T; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuchiya T; Mimaya J; Koizumi S; Ohta S; Miyake M; Takaue Y; Iwai A; Fujimoto T
    Cancer Res; 1998 Nov; 58(22):5182-7. PubMed ID: 9823330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.